Download Citation
Article Source:
GLIMSI: A real-world, multicenter study assessing the effectiveness and safety of Sitagliptin + Glimepiride + Metformin FDC in Indian patients with Type 2 diabetes
Zaveri K,
Kulkarni G,
Nair R,
Shanmugan G,
Dharmadhikari SA,
et al.
(2026)
GLIMSI: A real-world, multicenter study assessing the effectiveness and safety of Sitagliptin + Glimepiride + Metformin FDC in Indian patients with Type 2 diabetes.
PLOS ONE 21(2): e0337107.
https://doi.org/10.1371/journal.pone.0337107